Difference between revisions of "Paroxetine-vortioxetine"
From Psychiatrienet
| Line 8: | Line 8: | ||
* '''Day 15:''' start administration of vortioxetine in a normal dosage of 10 mg/day. | * '''Day 15:''' start administration of vortioxetine in a normal dosage of 10 mg/day. | ||
| info = | | info = | ||
| + | * Paroxetine is a strong inhibitor of CYP2D6, which metabolizes vortioxetine. | ||
* Occurrence of serotonin syndrome is theoretically possible, so caution is necessary. | * Occurrence of serotonin syndrome is theoretically possible, so caution is necessary. | ||
}} | }} | ||
Revision as of 16:14, 4 March 2015
| ||||||||||||||||||||||
| ||||||||||||||||||||||
Switch medication from paroxetine to vortioxetine.[1] [2]
Stop paroxetine - Day -7: reduce dosage of paroxetine to 20 mg/day, if this dosage is > 20 mg/day.
- Day 0: dosage of paroxetine is 20 mg/day.
- Day 1: reduce dosage of paroxetine to 10 mg/day.
- Day 8: reduce dosage of paroxetine to 5 mg/day.
- Day 15: stop administration of paroxetine.
Start vortioxetine- A wash-out period is not necessary.
- Day 15: start administration of vortioxetine in a normal dosage of 10 mg/day.
More information- Paroxetine is a strong inhibitor of CYP2D6, which metabolizes vortioxetine.
- Occurrence of serotonin syndrome is theoretically possible, so caution is necessary.
- ↑ Switches are based on literature references on this page and expert opinions of the authors. The authors have used pharmacokinetic and receptor affinity properties to determine the switch schedules
- ↑ Stahl, S. M. (2013). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). Cambridge University Press.
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.
